You are here: Industry Insights > Drug

News List

Novartis dumps Aveo drug as relationship sours fiercebiotech
July 09, 2018
Novartis has walked away from Aveo Pharmaceuticals’ AV-380 three years after paying $15 million (€13 million) upfront for the asset.
Orion takes repurposed heart failure drug into phase 3 for ALS fiercebiotech
July 09, 2018
Finnish drugmaker Orion Pharma is pressing ahead with a pivotal trial for its amyotrophic lateral sclerosis drug ODM-109, despite mixed results in a phase 2 trial.
Novartis spins off Alcon as CEO focuses drug search pharmafile
July 06, 2018
Novartis has announced a plan to spinoff Alcon – its eye care division – into a separately-traded standalone company.
FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy worldpharmanews
July 05, 2018
The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy
Pfizer names winners of Healthcare Hub Challenge pharmatimes
July 04, 2018
Medopad, Perfect Ward and Inhealthcare have been named as this year’s winners of Pfizer’s Healthcare Hub: London challenge.
Study finds drug reduces hearing loss in children with liver cancer pharmaceutical-technology
June 28, 2018
A study has found that a new drug sodium thiosulphate (STS) can reduce hearing loss in children treated for hepatoblastoma, a childhood liver cancer.
FDA Approves First Drug Comprised of Marijuana americanpharmaceuticalreview
June 27, 2018
The U.S. Food and Drug Administration (FDA) approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy
Roche's multiple sclerosis drug Ocrevus lowered patients' vaccine responses: study fiercevaccines
June 26, 2018
Roche’s multiple sclerosis newcomer Ocrevus was approved by the FDA last March bearing a warning about immunization.
Vertex doubles size of cystic fibrosis drug discovery site fiercebiotech
June 25, 2018
Vertex has more than doubled the size of the San Diego research site that discovered its key cystic fibrosis drugs.
GE introduces Biacore 8K+ contractpharma
June 19, 2018
GE Healthcare Life Sciences has introduced Biacore 8K+, an eight-needle high-sensitivity surface plasmon resonance (SPR) system that is able to automate over 4500 drug candidate–disease target binding experiments in one run.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 49 50 Next page